U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.2268G>A (p.Trp756Ter) AND Familial cancer of breast

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 31, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003500508.2

Allele description [Variation Report for NM_000465.4(BARD1):c.2268G>A (p.Trp756Ter)]

NM_000465.4(BARD1):c.2268G>A (p.Trp756Ter)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.2268G>A (p.Trp756Ter)
HGVS:
  • NC_000002.12:g.214728742C>T
  • NG_012047.3:g.85970G>A
  • NM_000465.4:c.2268G>AMANE SELECT
  • NM_001282543.2:c.2211G>A
  • NM_001282545.2:c.915G>A
  • NM_001282548.2:c.858G>A
  • NM_001282549.2:c.729G>A
  • NP_000456.2:p.Trp756Ter
  • NP_001269472.1:p.Trp737Ter
  • NP_001269474.1:p.Trp305Ter
  • NP_001269477.1:p.Trp286Ter
  • NP_001269478.1:p.Trp243Ter
  • LRG_297t1:c.2268G>A
  • LRG_297:g.85970G>A
  • LRG_297p1:p.Trp756Ter
  • NC_000002.11:g.215593466C>T
  • NG_012047.2:g.85963G>A
  • NM_000465.2:c.2268G>A
  • NR_104212.2:n.2233G>A
  • NR_104215.2:n.2176G>A
  • NR_104216.2:n.1432G>A
  • p.W756*
Protein change:
W243*
Links:
dbSNP: rs786202118
NCBI 1000 Genomes Browser:
rs786202118
Molecular consequence:
  • NR_104212.2:n.2233G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.2176G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104216.2:n.1432G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000465.4:c.2268G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001282543.2:c.2211G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001282545.2:c.915G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001282548.2:c.858G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001282549.2:c.729G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004293074Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Aug 31, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.

Laufer M, Nandula SV, Modi AP, Wang S, Jasin M, Murty VV, Ludwig T, Baer R.

J Biol Chem. 2007 Nov 23;282(47):34325-33. Epub 2007 Sep 11.

PubMed [citation]
PMID:
17848578

Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.

Adamovich AI, Banerjee T, Wingo M, Duncan K, Ning J, Martins Rodrigues F, Huang KL, Lee C, Chen F, Ding L, Parvin JD.

PLoS Genet. 2019 Mar;15(3):e1008049. doi: 10.1371/journal.pgen.1008049.

PubMed [citation]
PMID:
30925164
PMCID:
PMC6457558
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004293074.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Trp756*) in the BARD1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 22 amino acid(s) of the BARD1 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with BARD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 185366). This variant disrupts the C-terminal BRCT domain of BARD1 protein, which is required for chromosome stability and homology-directed repair (PMID: 17848578). A different variant (p.Val767fs) that lies downstream of this variant has been reported to affect BARD1 protein function (PMID: 30925164), this suggests that disruption of this region of the protein is causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024